<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0028-3746</journal-id>
<journal-title><![CDATA[Neumología y cirugía de tórax]]></journal-title>
<abbrev-journal-title><![CDATA[Neumol. cir. torax]]></abbrev-journal-title>
<issn>0028-3746</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Neumología y Cirugía de Tórax; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas; Sociedad Cubana de Neumología; Sociedad Paraguaya de Neumología; Sociedad Boliviana de Neumología.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0028-37462020000300204</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Selección en la diversidad de inhaladores: una actualización de bolsillo]]></article-title>
<article-title xml:lang="en"><![CDATA[Selection in the diversity of inhalers: A pocket upgrade]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bautista-Méndez]]></surname>
<given-names><![CDATA[Rafael]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Salinas-Lezama]]></surname>
<given-names><![CDATA[Erika]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bonola-Gallardo]]></surname>
<given-names><![CDATA[Liliana de Jesús]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pineda-Gudiño]]></surname>
<given-names><![CDATA[Rey David]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Magdaleno-Maldonado]]></surname>
<given-names><![CDATA[Gerardo Ezequiel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Secretaría de la Defensa Hospital Central Militar ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<volume>79</volume>
<numero>3</numero>
<fpage>204</fpage>
<lpage>207</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0028-37462020000300204&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0028-37462020000300204&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0028-37462020000300204&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Hoy en día, la administración de medicamentos inhalados representa la ruta de elección para aplicar fármacos dirigidos a trastornos respiratorios. Para la correcta aplicación del tratamiento inhalado de los fármacos es fundamental la selección adecuada del dispositivo para cada paciente así como la revisión de la técnica de administración. Existen distintas consideraciones que deben ser tomadas en cuenta para lograr que la terapia inhalada sea óptima: conocer a profundidad los dispositivos disponibles, sus peculiaridades y técnica de administración así como las características clínicas, comorbilidades, edad, capacidad de inhalación del paciente. Existen inhalados que precisan un flujo inspiratorio alto para realizar una inhalación rápida y profunda, otros donde se debe realizar una inhalación lenta y constante, ya que no precisan un flujo alto. El objetivo de este artículo es realizar una revisión de los distintos inhaladores disponibles en la actualidad, con la presentación de los diferentes tipos de dispositivos, presentaciones, dosis y nombres comerciales en nuestro país para facilitar la práctica diaria a la hora de prescribirlos. De igual forma, recuerda al neumólogo la importancia de conocer las características de cada uno y la importancia de entender las necesidades y capacidades del paciente para poder elegir correctamente el dispositivo idóneo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Today, the administration of inhaled medications represents the route of choice for applying drugs aimed at respiratory disorders. For the correct application of inhaled drug treatment, the proper selection of the device for each patient is essential, as well as the review of the administration technique. There are different considerations that must be taken into account to ensure that the inhaled therapy is optimal; To know in depth the available devices, their peculiarities and administration technique, as well as to take into account the clinical characteristics, comorbidities, age, inhalation capacity of the patient. There are inhales that require a high inspiratory flow to perform a rapid and deep inhalation, there are others where a slow and constant inhalation must be performed since they do not require a high flow. The goal of this narrative is to review the different inhalers currently available, with the presentation of the types of devices, doses and trade names in our country to facilitate daily practice when prescribing them. In the same way, it reminds the pulmonologist of the importance of knowing the characteristics of each one; and the importance of understanding the needs and capacities of the patient to be able to correctly choose the ideal device.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dosis medida]]></kwd>
<kwd lng="es"><![CDATA[inhaladores]]></kwd>
<kwd lng="es"><![CDATA[inhalador presurizado dosis medida]]></kwd>
<kwd lng="es"><![CDATA[medicamentos inhalados]]></kwd>
<kwd lng="es"><![CDATA[terapia respiratoria]]></kwd>
<kwd lng="en"><![CDATA[Measured dose]]></kwd>
<kwd lng="en"><![CDATA[inhalers]]></kwd>
<kwd lng="en"><![CDATA[pressurized metered dose inhaler]]></kwd>
<kwd lng="en"><![CDATA[inhaled medications]]></kwd>
<kwd lng="en"><![CDATA[respiratory therapy]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lavorini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mannini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chellini]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Challenges of inhaler use in the treatment of asthma and chronic obstructive pulmonary disease]]></article-title>
<source><![CDATA[EMJ Respir]]></source>
<year>2015</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>98-105</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Markus-Borghardt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kloft]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes]]></article-title>
<source><![CDATA[Can Respir J]]></source>
<year>2018</year>
<volume>2018</volume>
<page-range>2732017</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molimard]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Raherison]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lignot]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Depont]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Abouelfath]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Moore]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care]]></article-title>
<source><![CDATA[J Aerosol Med]]></source>
<year>2003</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>249-54</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lavorini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Magnan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dubus]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Voshaar]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Corbetta]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Broeders]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2008</year>
<volume>102</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>593-604</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Usmani]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Choosing the right inhaler for your asthma or COPD patient]]></article-title>
<source><![CDATA[Ther Clin Risk Manag]]></source>
<year>2019</year>
<volume>15</volume>
<page-range>461-72</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hochhaus]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A pharmacokinetic simulation tool for inhaled corticosteroids]]></article-title>
<source><![CDATA[AAPS J]]></source>
<year>2013</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>159-71</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsuda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Henry]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Particle transport and deposition: basic physics of particle kinetics]]></article-title>
<source><![CDATA[Compr Physiol]]></source>
<year>2013</year>
<volume>3</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1437-71</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dispositivos de inhalación para asma y EPOC]]></article-title>
<source><![CDATA[Bol Ter ANDAL]]></source>
<year>2018</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>9-19</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Labiris]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
<name>
<surname><![CDATA[Dolovich]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary drug delivery. part I: physiological factors affecting therapeutic effectiveness of aerosolized medications]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>2003</year>
<volume>56</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>588-99</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bonini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Usmani]]></surname>
<given-names><![CDATA[OS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The importance of inhaler devices in the treatment of COPD]]></article-title>
<source><![CDATA[COPD Res Pract]]></source>
<year>2015</year>
<volume>1</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Drug delivery to the small airways]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>1998</year>
<volume>157</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>S199-202</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olsson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bondesson]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Borgström]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Edsbäcker]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pulmonary drug metabolism, clearance, and absorption]]></article-title>
<source><![CDATA[Controlled pulmonary drug delivery]]></source>
<year></year>
<page-range>21-50</page-range><publisher-loc><![CDATA[New York, NY ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Consenso SEPAR-ALAT sobre terapia inhalada]]></article-title>
<source><![CDATA[Arch Bronconeumol]]></source>
<year>2013</year>
<volume>49</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>2-14</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cases]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Aragonés]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Toya]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Carreño]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Peiró]]></surname>
<given-names><![CDATA[MJF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dispositivos y guía de administración vía inhalatoria]]></article-title>
<source><![CDATA[Rev OFIL]]></source>
<year>2017</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-46</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanchis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gich]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Pedersen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review of errors in inhaler use: has patient technique improved over time?]]></article-title>
<collab>Aerosol Drug Management Improvement Team (ADMIT)</collab>
<source><![CDATA[Chest]]></source>
<year>2016</year>
<volume>150</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>394-406</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miravitlles]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soler-Cataluña]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Alcázar]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Viejo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Gracía-Río]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors affecting the selection of an inhaler device for COPD and the ideal device for different patient profiles. Results of EPOCA Delphi consensus]]></article-title>
<source><![CDATA[Pulm Pharmacol Ther]]></source>
<year>2018</year>
<volume>48</volume>
<page-range>97-103</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
